期刊文献+

pcDNA3/HA-moesin^(T558A)和pcDNA3/HA-moesin^(T558D)基因突变体构建与验证

Construction and validation of pcDNA3/HA-moesin^(T558A) and pcDNA3/HA-moesin^(T558D) gene mutants
下载PDF
导出
摘要 目的构建抑制型pcDNA3/HA-moesin^(T558A)与激活型pcDNA3/HA-moesin^(T558D)基因突变体,并在人脐静脉内皮细胞(HUVECs)中验证。方法设计特定的moesin^(T558A)、moesin^(T558D)基因突变引物,以pcDNA3/HA-moesin为模板,采用逆向PCR技术进行体外定点突变,以丙氨酸、天冬氨酸取代苏氨酸,获得抑制型pcDNA3/HA-moesin^(T558A)和激活型pcDNA3/HA-moesin^(T558D)基因突变体并测序。体外培养HUVECs,随机分为对照1组、pcDNA3/HA空载体组、pcDNA3/HA-moesin组以及对照2组、pcDNA3/HA-moesin^(T558A)组、pcDNA3/HA-moesin^(T558D)组,pcDNA3/HA空载体组、pcDNA3/HA-moesin组、pcDNA3/HA-moesin^(T558A)组、pcDNA3/HA-moesin^(T558D)组分别转染pcDNA3/HA空载体、pcDNA3/HA-moesin、pcDNA3/HA-moesin^(T558A)、pcDNA3/HA-moesin^(T558D),对照1组与对照2组不予转染。转染24 h,收集细胞,采用实时荧光定量PCR法检测moesin mRNA表达,采用Western blotting法和免疫荧光法检测moesin蛋白表达。结果经测序,目的基因moesin^(T558A)、moesin^(T558D)序列完全正确,第558位苏氨酸分别突变为丙氨酸、天冬氨酸,抑制型pcDNA3/HA-moesin^(T558A)和激活型pcDNA3/HA-moesin^(T558D)基因突变体构建成功。pcDNA3/HA-moesin组moesin mRNA相对表达量显著高于对照1组和pcDNA3/HA空载体组(t分别为16.688、16.649,P均<0.05),而pcDNA3/HA空载体组与对照1组比较差异无统计学意义(t=1.925,P>0.05)。pcDNA3/HA-moesin^(T558D)组、pcDNA3/HA-moesin^(T558A)组moesin mRNA相对表达量均显著高于对照2组(t分别为13.809、9.260,P均<0.05),pcDNA3/HA-moesin^(T558D)组与pcDNA3/HA-moesin^(T558A)组比较差异无统计学意义(t=2.364,P>0.05)。Western blotting结果显示,pcDNA3/HA-moesin^(T558A)组和pcDNA3/HA-moesin^(T558D)组均能观察到HA-moesin蛋白表达,而对照1组未观察到HA-moesin蛋白表达。免疫荧光结果显示,pcDNA3/HA-moesin组、pcDNA3/HA-moesin^(T558A)组和pcDNA3/HA-moesin^(T558D)组均能观察到HA-moesin荧光,而对照2组未观察到HA-moesin荧光。� Objective To construct suppressed pcDNA3/HA-moesin^(T558A) and activated pcDNA3/HA-moesin^(T558D) gene mutants and to verify their expression in human umbilical vein endothelial cells(HUVECs).Methods Specific moesin^(T558A) and moesin^(T558D) gene mutation primers were designed,and pcDNA3/HA-moesin was used as the template for in vitro targeted mutagenesis by reverse PCR,and threonine was replaced with alanine and aspartate to obtain suppressed pcDNA3/HA-moesin^(T558A) and activated pcDNA3/HA-moesin^(T558D) gene mutants and then they were sequenced.HUVECs cells were cultured in vitro and randomly divided into the control 1 group,pcDNA3/HA empty vector group,pcDNA3/HA-moesin group,and control 2 group,pcDNA3/HA-moesin^(T558A) group,and pcDNA3/HA-moesin^(T558D) group;the pcDNA3/HA empty vector group,pcDNA3/HA-moesin group,pcDNA3/HA-moesin^(T558A) group,and pcDNA3/HA-moesin^(T558D) group were transfected with pcDNA3/HA empty vector,pcDNA3/HA-moesin,pcDNA3/HA-moesin^(T558A),and pcDNA3/HA-moesin^(T558D),respectively,while the control 1 group and control 2 group were not transfected.The cells were transfected for 24 h.The moesin mRNA expression was detected by real-time fluorescence quantitative PCR,and the moesin protein expression was detected by Western blotting and immunofluorescence.Results After sequencing,the sequences of target genes moesin^(T558A) and moesin^(T558D) were completely correct,and the threonine at position 558 mutated into alanine and aspartate,respectively;the suppressed pcDNA3/HA-moesin^(T558A) and activated pcDNA3/HA-moesin^(T558D) mutants were successfully constructed.The relative expression of moesin mRNA in the pcDNA3/HA-moesin group was significantly higher than that in the control 1 group and the pcDNA3/HA empty vector group(t=16.688,16.649,both P<0.05),while there was no statistically significant difference between the pcDNA3/HA empty vector group and the control 1 group(t=1.925,P>0.05).The relative expression levels of moesin mRNA in the pcDNA3/HA-moesin^(T558D) and pcDNA3/HA-moesin^(T558
作者 刘红霞 陈力 王运林 罗卓章 黄巧冰 LIU Hongxia;CHEN Li;WANG Yunlin;LUO Zhuozhang;HUANG Qiaobing(Department of Endocrinology,Nanhai Hospital,Guangdong Provincial People's Hospital,Foshan 528000,China;不详)
出处 《山东医药》 CAS 2023年第13期6-9,14,共5页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81870210)。
关键词 膜突蛋白 pcDNA3/HA-moesin^(T558A) pcDNA3/HA-moesin^(T558D) 人脐静脉内皮细胞 membrane synuclein pcDNA3/HA-moesin^(T558A) pcDNA3/HA-moesin^(T558D) human umbilical vein endothelial cells
  • 相关文献

参考文献6

二级参考文献34

  • 1李强,郭晓华,朱艳军,陈波,邓建新,黄绪亮,黄巧冰.晚期糖基化终产物诱导内皮细胞紧密连接改变及其机制[J].中国动脉硬化杂志,2006,14(6):499-502. 被引量:9
  • 2Yuan SY, Breslin JW, Perrin R, et al. Microvascular permeability in diabetes and insulin resistanee. Microcirculation,2007,14:363-373. 被引量:1
  • 3Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation ,2006,114:597 -605. 被引量:1
  • 4Bretscher A. Regulation of cortical structure by the ezrin-radixinmoesin protein family. Curr Opin Cell Binl, 1999,11:109-116. 被引量:1
  • 5Koss M, Pfeiffer GR 2nd, Wang Y, et al. Ezrin/radixin/moesin proteins are phosphorylated by TNF-α and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol,2006,176 : 1218-1227. 被引量:1
  • 6Tsukita S, Yonemura Y, Tsukita S. ERM ( ezrin/radixin/moesin ) family:from cytoskeleton to signal transduction. Curr Opin Cell Biol, 1997,9:70-75. 被引量:1
  • 7Bierhaus A,Hofmann MA,Ziegle R,et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGEs concept. Cardiovasc Res, 1998,37:586-600. 被引量:1
  • 8[1]Sato N et al.J Cell Sci,1992;103:131 被引量:1
  • 9[2]Tsukita S et al.J Biol Chem,1999;274:34507 被引量:1
  • 10[3]Pearson MA et al.Cell,2000; 101:259 被引量:1

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部